DPP4 and neoplasm: Given the catalytic activity of CD26 on chemokines that guide effector T cells towards tumors, Ng and colleagues suggested that a decreased degradation of these chemokines enhances the trafficking of anti-tumor T cells into solid tumors, resulting in a better outcome (7).